Tri-Luma combines fluocinolone acetonide, hydroquinone and tretinoin in a prescription cream for short-term treatment of moderate-to-severe facial melasma under its label conditions. The manufacturer page provides study-design information and important safety details, rather than marketing it as an ordinary cosmetic brightener.

Its approved indication is narrower than “any dark spot.” The corticosteroid and tretinoin components are important distinctions from a hydroquinone-only preparation. Compare the full medicine label with the prescriber, including the limits on use and maintenance, rather than use a cosmetic-serum review as instructions for this combination.

Read the actual formulation

Tri-Luma contains three medicines: fluocinolone acetonide, hydroquinone and tretinoin. Its manufacturer describes short-term treatment of moderate-to-severe facial melasma under specific label conditions. The corticosteroid and retinoid are material differences from a compounded hydroquinone-and-kojic-acid cream. The prescriber should assess the full indication and warnings; a general dark-spot directory does not extend the medicine label to every pigmented spot. Tri-Luma Cream is listed as prescription hydroquinone combination. Read its current complete label before buying, because the headline active does not disclose every supporting ingredient, solvent or preservative.

A useful way to assess this option is to compare it with a product performing the same job. For Tri-Luma Cream, ask whether the attraction is the named active, the texture, the access route or a particular brand claim. Those reasons lead to different alternatives. A reader satisfied with an existing moisturizer may be choosing a treatment step; a reader mainly concerned about dryness may be deciding whether a separate serum adds anything useful.

The evidence question for this product

Melasma, post-inflammatory marks and sun-related spots are not one diagnosis. A dermatologist may need to examine a lesion before any lightening product is appropriate. That context does not independently verify an outcome for Tri-Luma Cream. The official source documents what its manufacturer or provider presents. The formulation-specific details above are useful for comparison, while a claim of better results would require evidence on the finished product and an appropriate comparator.

Routine fit and cautions

Hydroquinone needs a clinician-directed treatment window and monitoring. Unusual darkening or a blue-gray change should be reported promptly. With Tri-Luma Cream, the relevant discussion includes a prescription combination of fluocinolone acetonide, hydroquinone and tretinoin for labeled facial melasma use. Check the complete label and describe other leave-on products to a clinician if your skin is already irritated. A review cannot set a personal prescription schedule or identify the cause of a new skin change.

Cost and the decision to buy

The source snapshot records Confirm current price and size on the official page. For Tri-Luma Cream, confirm the actual selected size, quantity and purchase terms on the official page. Compare a retail bottle, a prescription supply and a consultation over the same period; their headline figures are not interchangeable. Subscription or bundle pricing is a separate purchase option, not a reason to assume that more products are necessary.

Our decision point is a prescription combination of fluocinolone acetonide, hydroquinone and tretinoin for labeled facial melasma use. The information above helps decide what to read next and what needs clarification before purchasing Tri-Luma Cream. Use the related product review for a specific alternative and the category comparison to see the options together. If the ingredient identity, intended use or cost remains uncertain, the official manufacturer or treating clinician is the appropriate source for that missing detail.

Sources and verification

Official pages establish product facts and provider claims. Clinical and regulatory sources answer separate evidence questions. Checked October 1, 2026. No medical reviewer is credited for this article.